As long as guys like Tom Ichim are actively involved with this company, I can wait. The FDA is notoriously tough on US drug releases, which is why you can normally buy stuff online from overseas long before it's approved here. I get that those looking for a run or profit this year were disappointed and dumped on the heels of that last PR, but if you really read it, there was nothing negative in it at all. Not a thing. just a request for additional safety data which I have to believe is 100% standard practice.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.